Sanctuary Advisors LLC Acquires 3,189 Shares of Bruker Co. (NASDAQ:BRKR)

Sanctuary Advisors LLC grew its position in Bruker Co. (NASDAQ:BRKR) by 35.1% during the 4th quarter, HoldingsChannel reports. The fund owned 12,278 shares of the medical research company’s stock after purchasing an additional 3,189 shares during the period. Sanctuary Advisors LLC’s holdings in Bruker were worth $700,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Wealth Enhancement Advisory Services LLC raised its stake in shares of Bruker by 1.4% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 13,287 shares of the medical research company’s stock valued at $779,000 after acquiring an additional 177 shares during the period. UMB Bank n.a. raised its stake in shares of Bruker by 37.5% in the fourth quarter. UMB Bank n.a. now owns 909 shares of the medical research company’s stock valued at $53,000 after acquiring an additional 248 shares during the period. Blue Trust Inc. raised its stake in shares of Bruker by 13.5% in the fourth quarter. Blue Trust Inc. now owns 2,164 shares of the medical research company’s stock valued at $127,000 after acquiring an additional 257 shares during the period. US Bancorp DE increased its stake in Bruker by 2.1% in the 3rd quarter. US Bancorp DE now owns 12,700 shares of the medical research company’s stock worth $877,000 after buying an additional 260 shares during the period. Finally, Coldstream Capital Management Inc. increased its stake in Bruker by 7.3% in the 3rd quarter. Coldstream Capital Management Inc. now owns 4,553 shares of the medical research company’s stock worth $312,000 after buying an additional 308 shares during the period. Hedge funds and other institutional investors own 79.52% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts recently commented on BRKR shares. The Goldman Sachs Group raised shares of Bruker from a “sell” rating to a “neutral” rating and set a $60.00 price target on the stock in a research note on Thursday, December 5th. Guggenheim reaffirmed a “buy” rating on shares of Bruker in a research note on Monday, February 24th. Wells Fargo & Company reduced their price target on shares of Bruker from $78.00 to $75.00 and set an “overweight” rating on the stock in a research note on Wednesday, November 6th. UBS Group started coverage on shares of Bruker in a research note on Tuesday, December 10th. They issued a “neutral” rating and a $66.00 price target on the stock. Finally, Bank of America raised their price target on shares of Bruker from $78.00 to $80.00 and gave the stock a “buy” rating in a research note on Friday, December 13th. Six research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $70.50.

Bruker Trading Down 1.1 %

NASDAQ BRKR opened at $47.22 on Friday. The company has a debt-to-equity ratio of 1.15, a quick ratio of 0.77 and a current ratio of 1.60. The company has a market capitalization of $7.16 billion, a price-to-earnings ratio of 62.13, a price-to-earnings-growth ratio of 2.16 and a beta of 1.16. The company’s 50-day simple moving average is $56.24 and its two-hundred day simple moving average is $59.72. Bruker Co. has a one year low of $46.41 and a one year high of $94.86.

Bruker (NASDAQ:BRKR) last released its quarterly earnings results on Thursday, February 13th. The medical research company reported $0.76 earnings per share for the quarter, beating analysts’ consensus estimates of $0.75 by $0.01. Bruker had a net margin of 3.36% and a return on equity of 21.01%. Equities analysts forecast that Bruker Co. will post 2.69 EPS for the current fiscal year.

Bruker Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, March 28th. Stockholders of record on Monday, March 17th will be issued a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.42%. The ex-dividend date is Monday, March 17th. Bruker’s dividend payout ratio is currently 26.32%.

Bruker Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.